Infliximab 71124-0031
Product NDC
71124-0031- Manufacturer
- Samsung Biologics Co. Ltd
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Product Type
- Drug For Further Processing
- Marketing Start
- July 8, 2023
- Listing Expires
- December 31, 2026
Active Ingredients
| Ingredient | Strength |
|---|---|
| Infliximab-Dyyb | 100 mg/1 |
Packaging Options(1)
1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (71124-0031-0)